The FDA said it has been investigating the carcinogen, called N-nitrosodimethylamine or NDMA, in blood pressure and heart failure medicines since last year, and is evaluating whether low levels pose a risk to patients.
"The FDA is not calling for individuals to stop taking ranitidine at this time; however, patients taking prescription ranitidine who wish to discontinue use should talk to their health care professional about other treatment options," the FDA said in the statement.Shares of Sanofi dipped on the news before rebounding. They were about flat in mid-morning trading. Sanofi declined to immediately comment.
Regarding capsule and any innovation in pharmacy and healthcare the answer is there are literally no profits for the healthcare practitioner, the insurance companies are hoarding your insurance premiums and paying below cost of the prescribed drugs that are covered.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »